Xinfengming Group Co., Ltd. (SHA:603225)
18.41
+0.79 (4.48%)
Apr 29, 2026, 11:29 AM CST
Xinfengming Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 68,640 | 64,821 | 59,899 | 47,538 | 41,205 | Upgrade
|
| Other Revenue | 2,917 | 2,270 | 1,569 | 3,250 | 3,565 | Upgrade
|
| Revenue | 71,557 | 67,091 | 61,469 | 50,787 | 44,770 | Upgrade
|
| Revenue Growth (YoY) | 6.66% | 9.15% | 21.03% | 13.44% | 21.05% | Upgrade
|
| Cost of Revenue | 67,950 | 63,443 | 57,975 | 49,084 | 40,102 | Upgrade
|
| Gross Profit | 3,607 | 3,647 | 3,493 | 1,703 | 4,668 | Upgrade
|
| Selling, General & Admin | 889.82 | 796.75 | 782.04 | 721.35 | 582.35 | Upgrade
|
| Research & Development | 1,350 | 1,209 | 1,198 | 1,078 | 915.21 | Upgrade
|
| Other Operating Expenses | 75.69 | -38.69 | 103.54 | 61.49 | -3.46 | Upgrade
|
| Operating Expenses | 2,314 | 1,976 | 2,080 | 1,865 | 1,496 | Upgrade
|
| Operating Income | 1,292 | 1,671 | 1,413 | -162.06 | 3,172 | Upgrade
|
| Interest Expense | -645.37 | -828.3 | -852.87 | -785.76 | -595.1 | Upgrade
|
| Interest & Investment Income | 257.61 | 372.58 | 349.91 | 254.5 | 86.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 70.59 | -63.61 | 57.48 | 32.46 | 13.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -58 | 12.74 | -31.61 | -28.12 | -19.91 | Upgrade
|
| EBT Excluding Unusual Items | 917.25 | 1,165 | 935.82 | -688.98 | 2,657 | Upgrade
|
| Gain (Loss) on Sale of Investments | -28.66 | -6.19 | 40.06 | -21.28 | -1.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.98 | 0.6 | -0.94 | 0.36 | -4.42 | Upgrade
|
| Asset Writedown | -1.64 | -0.89 | -0.81 | 1.66 | -9.49 | Upgrade
|
| Other Unusual Items | 200.53 | 98 | 200.27 | 242.25 | 31.14 | Upgrade
|
| Pretax Income | 1,089 | 1,256 | 1,174 | -465.99 | 2,673 | Upgrade
|
| Income Tax Expense | 69.7 | 156.38 | 88.25 | -260.45 | 418.89 | Upgrade
|
| Earnings From Continuing Operations | 1,020 | 1,100 | 1,086 | -205.54 | 2,254 | Upgrade
|
| Minority Interest in Earnings | -1.4 | 0.1 | - | - | - | Upgrade
|
| Net Income | 1,018 | 1,100 | 1,086 | -205.54 | 2,254 | Upgrade
|
| Net Income to Common | 1,018 | 1,100 | 1,086 | -205.54 | 2,254 | Upgrade
|
| Net Income Growth | -7.42% | 1.27% | - | - | 273.77% | Upgrade
|
| Shares Outstanding (Basic) | 1,476 | 1,507 | 1,509 | 1,468 | 1,436 | Upgrade
|
| Shares Outstanding (Diluted) | 1,476 | 1,507 | 1,509 | 1,468 | 1,445 | Upgrade
|
| Shares Change (YoY) | -2.05% | -0.11% | 2.75% | 1.61% | 3.03% | Upgrade
|
| EPS (Basic) | 0.69 | 0.73 | 0.72 | -0.14 | 1.57 | Upgrade
|
| EPS (Diluted) | 0.69 | 0.73 | 0.72 | -0.14 | 1.56 | Upgrade
|
| EPS Growth | -5.48% | 1.39% | - | - | 262.79% | Upgrade
|
| Free Cash Flow | -2,693 | -390.34 | 310.71 | -2,191 | -3,151 | Upgrade
|
| Free Cash Flow Per Share | -1.82 | -0.26 | 0.21 | -1.49 | -2.18 | Upgrade
|
| Dividend Per Share | 0.200 | 0.225 | 0.255 | - | 0.225 | Upgrade
|
| Dividend Growth | -11.11% | -11.77% | - | - | 73.08% | Upgrade
|
| Gross Margin | 5.04% | 5.44% | 5.68% | 3.35% | 10.43% | Upgrade
|
| Operating Margin | 1.81% | 2.49% | 2.30% | -0.32% | 7.09% | Upgrade
|
| Profit Margin | 1.42% | 1.64% | 1.77% | -0.40% | 5.04% | Upgrade
|
| Free Cash Flow Margin | -3.76% | -0.58% | 0.51% | -4.32% | -7.04% | Upgrade
|
| EBITDA | 4,762 | 4,650 | 4,254 | 2,362 | 5,439 | Upgrade
|
| EBITDA Margin | 6.65% | 6.93% | 6.92% | 4.65% | 12.15% | Upgrade
|
| D&A For EBITDA | 3,470 | 2,978 | 2,841 | 2,524 | 2,266 | Upgrade
|
| EBIT | 1,292 | 1,671 | 1,413 | -162.06 | 3,172 | Upgrade
|
| EBIT Margin | 1.81% | 2.49% | 2.30% | -0.32% | 7.09% | Upgrade
|
| Effective Tax Rate | 6.40% | 12.45% | 7.51% | - | 15.67% | Upgrade
|
| Revenue as Reported | 71,557 | 67,091 | 61,469 | 50,787 | 44,770 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.